ICAM1 and neoplasm: Figure 4B shows that the fluorescence intensity of the tumor region in the mice treated with ICAM‐1–Cy5.5 was markedly greater than that in the IgG–Cy5.5 control group at all the measured time points, confirming the specific targeting of tumor tissue by the ICAM‐1–Cy5.5 antibodies.